Edition:
India

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

4.09USD
19 Jan 2018
Change (% chg)

$0.11 (+2.76%)
Prev Close
$3.98
Open
$3.98
Day's High
$4.09
Day's Low
$3.86
Volume
60,469
Avg. Vol
164,900
52-wk High
$4.83
52-wk Low
$0.91

Chart for

About

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal... (more)

Overall

Beta: 0.94
Market Cap(Mil.): $113.17
Shares Outstanding(Mil.): 60.20
Dividend: --
Yield (%): --

Financials

BRIEF-Casi Pharmaceuticals Files For Stock Shelf Of Upto $100 Million

* CASI PHARMACEUTICALS INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING Source text: [http://bit.ly/2zaieHQ] Further company coverage:

14 Dec 2017

BRIEF-Casi pharmaceuticals Q3 loss per share $0.03

* Casi Pharmaceuticals reports third quarter 2017 financial results

14 Nov 2017

BRIEF-CASI PHARMACEUTICALS ANNOUNCES $23.8 MLN REGISTERED DIRECT OFFERING

* CASI PHARMACEUTICALS ANNOUNCES $23.8 MILLION REGISTERED DIRECT OFFERING LED BY EXISTING SHAREHOLDERS

13 Oct 2017

BRIEF-CASI provides pipeline development update

* CASI Pharmaceuticals Inc- CFDA has granted priority review for co's import drug registration clinical trial application for EVOMELA for injection Source text for Eikon: Further company coverage:

07 Sep 2017

BRIEF-Casi Pharmaceuticals reports Q2 loss per share $0.04

* Casi Pharmaceuticals reports second quarter 2017 financial results

14 Aug 2017

Competitors

Earnings vs. Estimates